The objective of the European LeukemiaNet is to integrate the 78 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 83 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care.
http://www.leukemia-net.org/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
1.1 seconds
16x16
Kompetenznetzwerk Leukaemie
Ruediger Hehlmann
Universita●●●●●●●●●●n Mannheim
Man●●●eim , DE, 68169
DE
View this contact
Kompetenznetzwerk Leukaemie
Ruediger Hehlmann
Universita●●●●●●●●●●n Mannheim
Man●●●eim , DE, 68169
DE
View this contact
SNTL Publishing GmbH & Co KG
Frank Hoffmann
Hege●●●●tz 1
Be●●in , DE, 10117
DE
View this contact
BUY YOUR DOMAIN
PSI-USA, Inc. dba Domain Robot (R68-LROR)
WHOIS : whois.publicinterestregistry.net
REFERRED :
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
262
SITE IP
46.4.70.46
LOAD TIME
1.122 sec
SCORE
6.2
European Leukemia Net: Network Info - leukemia, leukaemia, ... | leukemia-net.org Reviews
https://leukemia-net.org
The objective of the European LeukemiaNet is to integrate the 78 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 83 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care.
leukemia-net.org
European Leukemia Net: Diagnostics - diagnostics, leukemia, ...
https://www.leukemia-net.org/content/diagnostics
We comply with the. HONcode standard for trustworthy health. Created by: Hellenbrecht (ELIC) , last changed: 2008/10/26. Objectives are to integrate all major diagnostic groups from Europe into a European Platform on Leukemia Diagnostics. Morphological and immunological evaluation of peripheral blood and bone marrow are the cornerstones for the diagnosis of . Objectives are to integrate all major cytogenetic laboratories in a European cytogenetic platform to promote the analysis of .
European Leukemia Net: ELN-Meetings
https://www.leukemia-net.org/content/home/eln_meetings
We comply with the. HONcode standard for trustworthy health. Created by: Sina Hehn (ELIC) , generated 2007/03/19 , last changed: 2013/10/15. Annual Network Symposium of the European LeukemiaNet. How to join the European LeukemiaNet. European Treatment and Outcome Study. EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe. The ELN is funded through a Research Networking Programme (RNP), initiated by the European Science Foundation.
European Leukemia Net: Funding - leukemia, leukaemia, ...
https://www.leukemia-net.org/content/home/the_project/funding
We comply with the. HONcode standard for trustworthy health. Created by: Hellenbrecht (ELIC) , generated 2006/02/08, last changed: 2012/02/14. The European LeukemiaNet is funded by the European Community, 6th Framework Programme. Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe. Date of Preparation of Annex I.
European Leukemia Net: Network Info - leukemia, leukaemia, ...
https://www.leukemia-net.org/content/home
We comply with the. HONcode standard for trustworthy health. The European LeukemiaNet is a publicly funded research network of excellence. Goal is cure of leukemia by integration of European leukemia research and spread of excellence. The website delivers information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and further information about the disease. You can get information about the European LeukemiaNet in various european languages. MDS Pocket Card 2014.
European Leukemia Net: Leukemias - ELN, Leukemia, ALL, ...
https://www.leukemia-net.org/content/leukemias
We comply with the. HONcode standard for trustworthy health. Created by: Hellenbrecht (ELIC) , last changed: 2008/04/02. The Clinical Trials Platform integrates European expertise, explores and validates new therapeutic interventions and incorporates translational research to rapid applications in public health. Project 6: Acute Lymphoblastic Leukemia (ALL). Major aims are the cooperation in Europe on basic and (pre-) clinical research, as well as diagnostic methods and spread of . The ELN is funded thro...
TOTAL PAGES IN THIS WEBSITE
20
European Leukemia Network: Objectives - EUTOS, CML, leukemia, leukaemia, chronic myeloblastic leukemia, chronic ...
http://www.eutos.org/content/home/objectives
European Treatment and Outcome Study. The European LeukemiaNet (ELN) and Novartis have established the European Treatment and Outcome Study (EUTOS) for CML, an initiative designed to help European healthcare professionals to optimize treatment and achieve the best possible outcomes for patients with chronic lyeloid leukemia (CML). The project will foster ELN-activities, promote implementation of ELN management recommendations, improve understanding and treatment of CML, and enhance outcome of CML across ...
European Leukemia Network: Path to cure - pharmacological monitoring, blood level testing
http://www.eutos.org/content/path_to_cure
European Treatment and Outcome Study. About the subproject Pharmacological Monitoring. It is recommended that imatinib dosing should be considered where:. There is suspicion that the patient may be nonadherent with imatinib. There is suspicion that the patient may be experiencing a drug drug interaction. The patient is not responding to imatinib as well as he or she should be. The patient is experiencing side effects that are unusually severe for the dose of imatinib he or she is taking.
European Leukemia Network: Links
http://www.eutos.org/content/home/links
European Treatment and Outcome Study. CML Advodates Network For CML Patient Group Advocates. CML Alliance (for US residents only). For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph CML), Novartis Oncology introduces CML Alliance, a unique support program designed to help optimize outcomes in Ph CML patients. CML Alliance (for Healtcare Professionals outside the US). Main focus of the European LeukemiaNet is to Strengthen and develop scientific and technological excellence...
EUTOS for CML
http://www.eutos.org/content/home/index_print_eng.html
URL: http:/ www.eutos.org/content/e58/index eng.html. EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe. Japanese ELN recommendations for CML. Updated pocked card now available here. There are currently no items in. Tudy (EUTOS) is a collaboration between the European LeukemiaNet. Started in June 2007 running initially for 3 years to improve understanding of CML, promote best practise, and enhance treatment outcomes, through 4 key projects:.
European Leukemia Network: Japanese ELN recommendations for CML - ELN, recommendation, CML, Japanese language
http://www.eutos.org/content/home/news/japanese_eln_recommendations
European Treatment and Outcome Study. Japanese ELN recommendations for CML. ELN recommendations - background information in Japanese language available. The booklet can be ordered directly from ELIC. Please contact ELIC@em.uni-frankfurt.de. 2007-13 EUTOS: European Treatment and Outcome Study.
European Leukemia Network: Disclaimer - Disclaimer
http://www.eutos.org/content/disclaimer
European Treatment and Outcome Study. All research performed by the CML-Alliance will conform to relevant EU legislation such as:. The Charter of Fundamental Rights of the EU. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Directive 2001/18/EC of t...
European Leukemia Network: Online calculation of the EUTOS Score
http://www.eutos.org/content/home/eutos_score
European Treatment and Outcome Study. Online calculation of the EUTOS Score. The new EUTOS score predicts complete cytogenetic remission (CCgR) 18 months after the start of therapy, which is an important predictor for the course of disease. Patients without CCgR at this point of treatment are less likely to achieve one later on and are at a high risk of progressing to blastic and accelerated phase disease. 7 * basophils 4 * spleen size. Max distance from costal margin cm. 87 = high risk. Hasford J et al:...
European Leukemia Network: Information for Press and Media - Press, Media, Information, CML,
http://www.eutos.org/content/home/press__media/press_information
European Treatment and Outcome Study. Information for Press and Media. Press Release 26 Jun 2015 (German). Europaweites Register von CML-Patienten offenbart Wirksamkeit der Therapien und Handlungsbedarf. Key slides EUTOS, February 2012. Key slides EUTOS.ppt. EUTOS press release final 21 Oct 2010. EUTOS press release final 21 Oct 2010. GCT 8603 EUTOS for CML 18 Oct 2010. GCT 8603 EUTOS for CML backgrounder FINAL 18 Oct 2010. Created by: Hehn (ELIC) , generated 2007/12/19 , last changed: 2015/06/29.
European Leukemia Network: Calendar
http://www.eutos.org/content/home/calendar
European Treatment and Outcome Study. There are currently no items in. 2007-13 EUTOS: European Treatment and Outcome Study.
European Leukemia Network: Objectives
http://www.eutos.org/content/spread_of_excellence/objectives
European Treatment and Outcome Study. Objectives of Spread of Excellence. Ensure all physicians receive high-quality medical education and resources that support them in caring for patients with CML. Promote implementation of CML management recommendations. Improve understanding and treatment of CML and enhance outcomes of CML across Europe and globally. Raise awareness of the cooperation and Foster ELN activities. Created by: Hellenbrecht , generated 2007/12/19 , last changed: 2011/05/31.
TOTAL LINKS TO THIS WEBSITE
262
leukemia-lymphoma-cancer.blogspot.com
Leukemia-Lymphoma-Cancer
Tuesday, June 17, 2008. Leukemia For Twins and Stem Cells Solutions. Having stem cells extracted from the cord blood at birth and stored in a cord blood bank or a stem cells bank. Is a way to protect your child from future diseases. It can be very useful as it contains hematopoietic stem cells, progenitor cells. The stem cells in the cord blood are mainly used to treat blood and immune system related genetic diseases, cancers and blood disorders like diabetes or leukemia. Wednesday, November 21, 2007.
leukemia-lymphoma.blogspot.com
leukemia-lymphoma
Saturday, September 15, 2007. Many patients with leukemia take part in clinical trials (treatment studies). Clinical trials help doctors find out whether a new treatment is both safe and effective. They also help doctors answer questions about how the treatment works and what side effects it causes. Which explains some of the possible benefits and risks of treatment studies. One way to learn about clinical trials is through PDQ, a computerized resource developed by the National Cancer Institute. PDQ ...
Patrick Walby Monica Zech
Patrick Walby and The Leukemia Society. Man and Woman of the Year. The Leukemia and Lymphoma Society. Patrick Walby Monica Zech. Patrick Walby and Monica Zech. And his brother Philip Walby. Are the founders of Brake Depot. Companies that have given back to the comunity. Brake Team and Brake Depot are auto repair shops that specialize in brake repair. Photo is Patrick of the brakebrothers. And Monica Zech is from Traffic Watch. Click logo to go to Leukemia-Lymphoma Home. On May 10,. Although someone new i...
Home Page
We will use chronic lymphocytic leukemia (CLL) –the most common adult leukemia in the western world- as an ideally suited model system, but expect to identify general mechanisms contributing to cancer cell resistance.
European Leukemia Net: Network Info - leukemia, leukaemia, ...
We comply with the. HONcode standard for trustworthy health. The European LeukemiaNet is a publicly funded research network of excellence. Goal is cure of leukemia by integration of European leukemia research and spread of excellence. The website delivers information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and further information about the disease. You can get information about the European LeukemiaNet in various european languages. MDS Pocket Card 2014.
The Journey and Courage Through Leukemia
The Journey and Courage Through Leukemia. The Journey and Courage Through Leukemia. Information for parents or gardians concerning childhood Cancer. Free activities , books and videos for children with life trama. STANDING FAST THROUGH LEUKEMIA. Feel free to search the web here. Sites for Teachers has everything you need to stay current at school while in the hospital. Sunday, November 10, 2013. Leukemia: Bone Marrow and Blood Formation. 160; . Many of the blood cells that comprise the bloodstream with...
Leukemia Research – Research Foundation
Welcome to the Leukemia Research Foundation! Thank you for visiting the Leukemia Research Foundation UK. We are one of the oldest founded foundations for blood cancer and have been around since 1976 when the foundation was founded. Funding various projects as well as new major developments in patient care, we have made steady progress in reaching our goals to eradicate cancer. Over 50 Years of Research. The Leukemia Research Foundation. Was started in 1976. Close to Finding a Cure.
Home Page
We will use chronic lymphocytic leukemia (CLL) –the most common adult leukemia in the western world- as an ideally suited model system, but expect to identify general mechanisms contributing to cancer cell resistance.
leukemia-right-information.com
白血病の正しい知識を知っておこう
白血病 という病気を抱えながら 治療をしない というのは不安があるかもしれません。 Laquo; Older Entries. Powered by Wordpress Themes. Design by Reality Software. 白血病の正しい知識を知っておこう 2015 Theme design by Kerastase.
leukemia-skywalker.blogspot.com
To Whom It May Concern...
To Whom It May Concern. Its finals week and I have quite a bit of studying/ writing to do, so today I am leaving you with a short, and hopefully sweet, post! But why is this important? Since the movie starts off in this unknown dreamscape image, that we later learn is both a mix of reality and fantasy, we are placed in an awkward position. do we believe the events that are about to take place or do we question each action to find the truth? Naturally Born And Bred. Yet I would also like to comment on an ...
